CardiovascularORALStandard

ROSUVASTATIN CALCIUM

Standard Dose

EQ 40MG BASE

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview ROSUVASTATIN CALCIUM is listed in Drugs@FDA under application 212059 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ROSUVASTATIN CALCIUM Form and strength TABLET;ORAL - EQ 40MG BASE Sponsor ZHEJIANG YONGTAI Submission history Latest submission status date: 2022-02-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview ROSUVASTATIN CALCIUM is listed in Drugs@FDA under application 212059 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ROSUVASTATIN CALCIUM Form and strength TABLET;ORAL - EQ 40MG BASE Sponsor ZHEJIANG YONGTAI Submission history Latest submission status date: 2022-02-08 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.